Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art

Seminars in Cell and Developmental Biology

Volumn 67, Issue , 2017, Pages 23-28

  Fanini, Francesca ^a   Fabbri, Muller ^b  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; Immune system; Microenvironment; microRNAs; Tumor derived exosomes

Indexed keywords

GENOMIC DNA; MESSENGER RNA; MICRORNA; TUMOR PROTEIN;

CANCER CELL; CELL MATURATION; DENDRITIC CELL; EXOSOME; HUMAN; IMMUNE DYSREGULATION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOCYTE; MACROPHAGE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; CELL COMMUNICATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPH NODE METASTASIS; METABOLISM; NEOPLASM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR ESCAPE; TUMOR INVASION;

BIOLOGICAL TRANSPORT; CELL COMMUNICATION; DENDRITIC CELLS; EXOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNITY, INNATE; LYMPHATIC METASTASIS; LYMPHOCYTES; MACROPHAGES; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 85008323150     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2016.12.004     Document Type: Review

References (65)

1. Taylor, D.D., Chou, I.N., Black, P.H., Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem. Biophys. Res. Commun. 113 (1983), 470–476.
2. Taylor, D.D., Taylor, C.G., Jiang, C.G., Black, P.H., Characterization of plasma membrane shedding from murine melanoma cells. Int. J. Cancer 41 (1988), 629–635.
3. Taylor, D.D., Gercel-Taylor, C., Lyons, K.S., Stanson, J., Whiteside, T.L., T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin. Cancer Res. 9 (2003), 5113–5119.
4. Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L., Turbide, C., Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262 (1987), 9412–9420.
5. Keller, S., Ridinger, J., Rupp, A.-K., Janssen, J.W.G., Altevogt, P., Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med., 9, 2011, 86, 10.1186/1479-5876-9-86.
6. Poliakov, A., Spilman, M., Dokland, T., Amling, C.L., Mobley, J.A., Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate 69 (2009), 159–167, 10.1002/pros.20860.
7. Sharma, S., Gillespie, B.M., Palanisamy, V., Gimzewski, J.K., Quantitative nano-structural and single molecule force spectroscopy bio-molecular analysis of human saliva derived exosomes. Langmuir 27 (2011), 14394–14400, 10.1021/la2038763.
8. Skriner, K., Adolph, K., Jungblut, P.R., Burmester, G.R., Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 54 (2006), 3809–3814, 10.1002/art..22276.
9. Cocucci, E., Meldolesi, J., Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 25 (2015), 364–372, 10.1016/j.tcb.2015.01.004.
10. Wieckowski, E., Whiteside, T.L., Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles. Immunol. Res. 36 (2006), 247–254, 10.1385/IR:36:1:247.
11. Boyiadzis, M., Whiteside, T.L., Information transfer by exosomes: a new frontier in hematologic malignancies. Blood Rev. 29 (2015), 281–290, 10.1016/j.blre.2015.01.004.
12. Bobrie, A., Thery, C., Exosomes and communication between tumours and the immune system: are all exosomes equal?. Biochem Soc. Trans. 41 (2013), 263–267, 10.1042/BST20120245.
13. Gabrielsson, S., Scheynius, A., Exosomes in immunity and cancer–friends or foes?. Semin. Cancer Biol. 28 (2014), 1–2, 10.1016/j.semcancer.2014.06.007.
14. Robbins, P.D., Morelli, A.E., Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol. 14 (2014), 195–208, 10.1038/nri3622.
15. Kim, J.W., Wieckowski, E., Taylor, D.D., Reichert, T.E., Watkins, S., Whiteside, T.L., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 11 (2005), 1010–1020.
16. Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200 (2013), 373–383, 10.1083/jcb.201211138.
17. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659, 10.1038/ncb1596.
18. Bartel, D.P., MicroRNAs: genomics biogenesis mechanism, and function. Cell 116 (2004), 281–297.
19. Kozomara, A., Griffiths-Jones, S., miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42:Jan (Database issue) (2014), D68–D73, 10.1093/nar/gkt1181 Epub 2013 Nov 25. (n.d.).
20. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:1 (2005), 15–20 Jan 14(n.d.).
21. Lytle, J.R., Yario, T.A., Steitz, J.A., Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl. Acad. Sci. U. S. A. 104:23 (2007), 9667–9672.
22. Forman, J.J., Legesse-Miller, A., Coller, H.A., A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl. Acad. Sci. U. S. A. 105:39 (2008), 14879–14884, 10.1073/pnas.0803230105.
23. Ambros, V., The functions of animal microRNAs. Nature 431:7006 (2004), 350–355.
24. Vasudevan, S., Tong, Y., Steitz, J.A., Switching from repression to activation: microRNAs can up-regulate translation. Science 318:5858 (2007), 1931–1934.
25. Melo, S.A., Sugimoto, H., O'Connell, J.T., Kato, N., Villanueva, A., Vidal, A., Qiu, L., Vitkin, E., Perelman, L.T., Melo, C.A., Lucci, A., Ivan, C., Calin, G.A., Kalluri, R., Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 26:5 (2014), 707–721, 10.1016/j.ccell.2014.09.005.
26. Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P.J., Chudnovskiy, A., Berger, C., Ryan, R.J.H., Iwamoto, Y., Marinelli, B., Gorbatov, R., Forghani, R., Novobrantseva, T.I., Koteliansky, V., Figueiredo, J.-L., Chen, J.W., Anderson, D.G., Nahrendorf, M., Swirski, F.K., Weissleder, R., Pittet, M.J., Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. 109 (2012), 2491–2496, 10.1073/pnas.1113744109.
27. Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., Zhang, J., Cui, X., Zheng, F., Li, H., Yao, H., Su, F., Song, E., A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 25 (2014), 605–620, 10.1016/j.ccr.2014.03.021.
28. Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder, L.A., Pollard, J.W., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225, 10.1038/nature10138.
29. Marelli, G., Allavena, P., Erreni, M., Tumor-associated macrophages, multi-tasking cells in the cancer landscape, Cancer Res. Front 1 (2015), 149–161, 10.17980/2015.149.
30. Colvin, E.K., Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front. Oncol., 4, 2014, 137, 10.3389/fonc.2014.00137.
31. Marton, A., Vizler, C., Kusz, E., Temesfoi, V., Szathmary, Z., Nagy, K., Szegletes, Z., Varo, G., Siklos, L., Katona, R.L., Tubak, V., Howard, O.M.Z., Duda, E., Minarovits, J., Nagy, K., Buzas, K., Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro. Immunol. Lett. 148 (2012), 34–38, 10.1016/j.imlet.2012.07.006.
32. Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G.J., Zanesi, N., Crawford, M., Ozer, G.H., Wernicke, D., Alder, H., Caligiuri, M.A., Nana-Sinkam, P., Perrotti, D., Croce, C.M., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2110–E22116, 10.1073/pnas.1209414109.
33. Challagundla, K.B., Wise, P.M., Neviani, P., Chava, H., Murtadha, M., Xu, T., Kennedy, R., Ivan, C., Zhang, X., Vannini, I., Fanini, F., Amadori, D., Calin, G.A., Hadjidaniel, M., Shimada, H., Jong, A., Seeger, R.C., Asgharzadeh, S., Goldkorn, A., Fabbri, M., Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J. Natl. Cancer Inst., 107, 2015, 10.1093/jnci/djv135.
34. Jang, J.-Y., Lee, J.-K., Jeon, Y.-K., Kim, C.-W., Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer, 13, 2013, 421, 10.1186/1471-2407-13-421.
35. Squadrito, M.L., Pucci, F., Magri, L., Moi, D., Gilfillan, G.D., Ranghetti, A., Casazza, A., Mazzone, M., Lyle, R., Naldini, L., De Palma, M., miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep. 1 (2012), 141–154, 10.1016/j.celrep.2011.12.005.
36. Chen, Y., Wang, S.-X., Mu, R., Luo, X., Liu, Z.-S., Liang, B., Zhuo, H.-L., Hao, X.-P., Wang, Q., Fang, D.-F., Bai, Z.-F., Wang, Q.-Y., Wang, H.-M., Jin, B.-F., Gong, W.-L., Zhou, T., Zhang, X.-M., Xia, Q., Li, T., Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer. Cell Rep. 7 (2014), 1982–1993, 10.1016/j.celrep.2014.05.007.
37. Sonda, N., Simonato, F., Peranzoni, E., Calì B., Bortoluzzi, S., Bisognin, A., Wang, E., Marincola, F.M., Naldini, L., Gentner, B., Trautwein, C., Sackett, S.D., Zanovello, P., Molon, B., Bronte, V., MiR-142-3p prevents macrophage differentiation during cancer-Induced myelopoiesis. Immunity 38 (2013), 1236–1249, 10.1016/j.immuni.2013.06.004.
38. Medzhitov, R., Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 (2001), 135–145, 10.1038/35100529.
39. Okamoto, M., Oshikawa, T., Tano, T., Ahmed, S.U., Kan, S., Sasai, A., Akashi, S., Miyake, K., Moriya, Y., Ryoma, Y., Saito, M., Sato, M., Mechanism of anticancer host response induced by OK-432 a streptococcal preparation, mediated by phagocytosis and Toll-like receptor 4 signaling. J. Immunother. 29 (2006), 78–86.
40. Gabrilovich, D., Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4 (2004), 941–952, 10.1038/nri1498.
41. Condamine, T., Gabrilovich, D.I., Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32 (2011), 19–25, 10.1016/j.it.2010.10.002.
42. Liu, Y., Xiang, X., Zhuang, X., Zhang, S., Liu, C., Cheng, Z., Michalek, S., Grizzle, W., Zhang, H.-G., Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 176 (2010), 2490–2499, 10.2353/ajpath.2010.090777.
43. Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W.E., Falkson, C., Zhang, H.-G., Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J. Immunol. 178 (2007), 6867–6875.
44. Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., Rivoltini, L., Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 66 (2006), 9290–9298, 10.1158/0008-5472.CAN-06-1819.
45. Szafranska, A.E., Davison, T.S., John, J., Cannon, T., Sipos, B., Maghnouj, A., Labourier, E., Hahn, S.A., MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26 (2007), 4442–4452, 10.1038/sj.onc.1210228.
46. Greither, T., Grochola, L.F., Udelnow, A., Lautenschlager, C., Wurl, P., Taubert, H., Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 126 (2010), 73–80, 10.1002/ijc.24687.
47. Zhou, M., Chen, J., Zhou, L., Chen, W., Ding, G., Cao, L., Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell. Immunol. 292 (2014), 65–69, 10.1016/j.cellimm.2014.09.004.
48. Ding, G., Zhou, L., Qian, Y., Fu, M., Chen, J., Chen, J., Xiang, J., Wu, Z., Jiang, G., Cao, L., Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6 (2015), 29877–29888, 10.18632/oncotarget.4924.
49. Que, L., Lin, Ri-sheng, Ding, Cheng, Wu, Guo-pin, Cao, Zheng-rong, Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer. J. Zhejiang Univ. B 17 (2016), 352–360, 10.1631/jzus.B1500305.
50. Berzins, S.P., Ritchie, D.S., Natural killer T cells: drivers or passengers in preventing human disease?. Nat. Rev. Immunol. 14 (2014), 640–646, 10.1038/nri3725.
51. Donatelli, S.S., Zhou, J.-M., Gilvary, D.L., Eksioglu, E.A., Chen, X., Cress, W.D., Haura, E.B., Schabath, M.B., Coppola, D., Wei, S., Djeu, J.Y., TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 4203–4208, 10.1073/pnas.1319269111.
52. Noman, M.Z., Buart, S., Romero, P., Ketari, S., Janji, B., Mari, B., Mami-Chouaib, F., Chouaib, S., Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Cancer Res. 72 (2012), 4629–4641, 10.1158/0008-5472.CAN-12-1383.
53. Berchem, G., Noman, M.Z., Bosseler, M., Paggetti, J., Baconnais, S., Le cam, E., Nanbakhsh, A., Moussay, E., Mami-Chouaib, F., Janji, B., Chouaib, S., Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer. Oncoimmunology, 2016, 5, 10.1080/2162402X.2015.1062968.
54. Tang, B., Wu, W., Wei, X., Li, Y., Ren, G., Fan, W., Activation of glioma cells generates immune tolerant NKT cells. J. Biol. Chem. 289 (2014), 34595–34600, 10.1074/jbc.M114.614503.
55. Sakaguchi, S., Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004), 531–562, 10.1146/annurev.immunol.21.120601.141122.
56. Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance. Cell 133 (2008), 775–787, 10.1016/j.cell.2008.05.009.
57. Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., Yao, J., Jin, L., Wang, H., Yang, Y., Fu, Y.-X., Wang, F.-S., Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132 (2007), 2328–2339, 10.1053/j.gastro.2007.03.102.
58. Quezada, S.A., Peggs, K.S., Simpson, T.R., Shen, Y., Littman, D.R., Allison, J.P., Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J. Exp. Med. 205 (2008), 2125–2138, 10.1084/jem.20080099.
59. Zhou, Q., Bucher, C., Munger, M.E., Highfill, S.L., Tolar, J., Munn, D.H., Levine, B.L., Riddle, M., June, C.H., Vallera, D.A., Weigel, B.J., Blazar, B.R., Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood 114 (2009), 3793–3802, 10.1182/blood-2009-03-208181.
60. Yin, Y., Cai, X., Chen, X., Liang, H., Zhang, Y., Li, J., Wang, Z., Chen, X., Zhang, W., Yokoyama, S., Wang, C., Li, L., Li, L., Hou, D., Dong, L., Xu, T., Hiroi, T., Yang, F., Ji, H., Zhang, J., Zen, K., Zhang, C.-Y., Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Cell Res. 24 (2014), 1164–1180, 10.1038/cr.2014.121.
61. Wang, B., Wang, Q., Wang, Z., Jiang, J., Yu, S.-C., Ping, Y.-F., Yang, J., Xu, S.-L., Ye, X.-Z., Xu, C., Yang, L., Qian, C., Wang, J.M., Cui, Y.-H., Zhang, X., Bian, X.-W., Metastatic consequences of immune escape from NK cell cytotoxicity by human Breast cancer stem cells. Cancer Res. 74 (2014), 5746 LP–5757 LP (abstract) http://cancerres.aacrjournals.org/content/74/20/5746.
62. Xie, J., Liu, M., Li, Y., Nie, Y., Mi, Q., Zhao, S., Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell. Mol. Immunol. 11 (2014), 495–502, 10.1038/cmi.2014.30.
63. Tsukerman, P., Stern-Ginossar, N., Gur, C., Glasner, A., Nachmani, D., Bauman, Y., Yamin, R., Vitenshtein, A., Stanietsky, N., Bar-Mag, T., Lankry, D., Mandelboim, O., MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res. 72 (2012), 5463–5472, 10.1158/0008-5472 (CAN-11-2671).
64. Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., Garcia-Santos, G., Ghajar, C., Nitadori-Hoshino, A., Hoffman, C., Badal, K., Garcia, B.A., Callahan, M.K., Yuan, J., Martins, V.R., Skog, J., Kaplan, R.N., Brady, M.S., Wolchok, J.D., Chapman, P.B., Kang, Y., Bromberg, J., Lyden, D., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18 (2012), 883–891, 10.1038/nm.2753.
65. Whiteside, T.L., Tricks tumors use to escape from immune control. Oral Oncol. 45 (2009), e119–e123, 10.1016/j.oraloncology.2009.03.006.